Search results
2 new COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 5 hours agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
...-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on...
ThePress.net· 1 day agoConjugates of different active pharmaceutical intermediates (API) such as proteins, peptides, macrocycles, oligonucleotides, and small molecules, all with high drug antibody
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
GuruFocus.com via Yahoo Finance· 21 hours agoRevenue: Grew 7% year-over-year to $3.1 billion, excluding COVID antibodies contributions. Net Income: First quarter diluted net income per share was $9.55. Free Cash Flow: Generated $1.< ...
CDC says bird flu viruses "pose pandemic potential," cites major knowledge gaps
CBS News· 11 hours agoBird flu continues to appear to pose a "low risk to the general public" for now, the Centers for...
... III Randomized, Double-Masked Vehicle Controlled VELOS-4 Trial Evaluating Tanfanercept for...
NBC 17 Raleigh· 17 hours agoHanAll has initiated a Phase III VELOS-4 study to evaluate the efficacy and safety of tanfanercept in dry eye based on the findings from the previous Phase III VELOS-3 study ...
FDA Issues Final Rule on Laboratory-Developed Tests | JD Supra
JD Supra· 2 days agoOn April 29, 2023, the FDA announced a final rule on regulation of laboratory developed tests (LDTs). The rule explicitly categorizes in vitro...
New approach could lead to universal flu vaccine
Futurity· 15 hours agoResearchers have opened a new avenue in the attack against influenza viruses by creating a vaccine that encourages the immune system to target a portion...
OraSure Technologies (NASDAQ:OSUR) Upgraded to Buy by StockNews.com
ETF DAILY NEWS· 2 days agoStockNews.com upgraded shares of OraSure Technologies (NASDAQ:OSUR – Free Report) from a hold rating to a buy rating in a report issued on Wednesday. Separately, Evercore ISI cut their price ...
AI may help diagnose rare diseases years earlier
United Press International via Yahoo News· 10 hours agoArtificial intelligence might be able to identify patients who have rare diseases years earlier than they would typically be diagnosed, a new study says.
Cytokine Release Syndrome: What to Know
Verywell Health via Yahoo News· 1 day agoCytokine release syndrome (CRS) occurs when the immune system responds to infection or immunotherapy drugs more aggressively than it should. Learn more...
